Thomas A. Raffin
CIK 1512119 · last filed 2025-07-10
Thomas A. Raffin is a corporate insider who has filed 31 SEC Form 4 insider transactions across 4 companies since 2011. Across all open-market trades the lifetime net is −$23.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.32M
4
31
-$23.60M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LUMOS PHARMA, INC. (LUMO) Delisted | Director | 0 | $4.34 | $0 | $9.7K | 7 | 2024-12-13 |
| Akoya Biosciences, Inc. (AKYA) Delisted | Director | 2,166,896 | $1.29 | $2.80M | $10.10M | 6 | 2024-06-05 |
| LUMOS PHARMA, INC. (NLNK) Delisted | Director | 64,621 | — | — | -$1.13M | 14 | 2019-08-02 |
| LDRH | 10%+ Owner | 338,057 | $24.62 | $8.32M | -$32.58M | 3 | 2014-10-21 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-10 | — | Other (J) | −17,909,839 | $0 | |
| 2024-12-13 | LUMOS PHARMA, INC. (LUMO) Delisted | Disp (D) | −9,406 | $0 | EDGAR |
| 2024-06-07 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | Akoya Biosciences, Inc. (AKYA) Delisted | Buy (P) | +2,020,000 | $10.10M | EDGAR |
| 2023-06-05 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-26 | LUMOS PHARMA, INC. (LUMO) Delisted | Buy (P) | +1,150 | $9.7K | EDGAR |
| 2022-06-03 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-09 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | — | $0 | EDGAR |